Patients may experience increased pain or discomfort at the injection site if the medication is delivered into muscle rather than subcutaneous tissue
These modifications include acylation of the peptide backbone with a spacer and a C-18 fatty di-acid chain to lysine at position 26, which mediates strong binding to albumin and potentially results in reduced renal clearance, and an amino-acid substitution in position 8, which results in reduced susceptibility to dipeptidyl peptidase-4 (DPP-4) degradation
The role of genetic testing For researchers with thyroid nodules who want maximum reassurance before starting tirzepatide, genetic testing offers a definitive answer about MEN 2 risk, the primary genetic condition that contraindicates GLP-1 receptor agonist use
The second common error is overstating Jardiance's weight-loss potential
The combination of fever, jaundice, and right upper quadrant pain (Charcot's triad) suggests cholangitis, a medical emergency requiring immediate care
Wegovy users have also reported hospitalization due to gastroparesis (stomach paralysis), was not mentioned on the drugs warning label until October 2025